Brain surgery sedative may shield patients from secondary injury
NCT ID NCT04266665
First seen Jan 04, 2026 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This study tested whether the sedative dexmedetomidine can protect the brain during surgery to remove a brain tumor. Fifty-six adults having brain tumor surgery received either dexmedetomidine or a placebo. The goal was to see if the drug reduces brain inflammation, improves oxygen supply, and prevents cognitive problems after surgery. Results may help guide safer anesthesia for brain tumor patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AHEPA University Hospital
Thessaloniki, 54636, Greece
Conditions
Explore the condition pages connected to this study.